Published in Antivir Ther on January 01, 2008
Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries. Pharmacoeconomics (2011) 1.89
Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review. PLoS One (2009) 1.31
Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries. Bull World Health Organ (2014) 1.19
Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti. PLoS Med (2011) 0.97
Claims on health care: a decision-making framework for equity, with application to treatment for HIV/AIDS in South Africa. Health Policy Plan (2010) 0.93
Economic evaluation of ART in resource-limited countries. Curr Opin HIV AIDS (2010) 0.92
Financing equitable access to antiretroviral treatment in South Africa. BMC Health Serv Res (2010) 0.91
Modeling the cost-effectiveness of HIV treatment: how to buy the most 'health' when resources are limited. Curr Opin HIV AIDS (2013) 0.79
Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco. AIDS Res Hum Retroviruses (2011) 0.77
An assessment of interactions between global health initiatives and country health systems. Lancet (2009) 10.53
Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med (2010) 10.44
High level of burnout in intensivists: prevalence and associated factors. Am J Respir Crit Care Med (2007) 3.92
When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antivir Ther (2006) 2.85
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis. Lancet Infect Dis (2013) 2.51
Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology (Berl) (2014) 2.37
Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med (2002) 2.33
Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS (2002) 2.21
Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance? PLoS One (2010) 1.98
NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med (2005) 1.85
Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis. PLoS Med (2009) 1.81
Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon. Antivir Ther (2013) 1.68
Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol (2007) 1.60
Is maternal posturing during labor efficient in preventing persistent occiput posterior position? A randomized controlled trial. Am J Obstet Gynecol (2012) 1.59
Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon. AIDS (2010) 1.57
Association of antiretroviral therapy adherence and health care costs. Ann Intern Med (2010) 1.57
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study. Antivir Ther (2003) 1.55
Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care. J Palliat Med (2012) 1.54
Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial. Am J Kidney Dis (2008) 1.53
Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System. Eur J Cardiothorac Surg (2013) 1.50
Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy? Eur J Cardiothorac Surg (2005) 1.49
Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.44
Financial barriers to HIV treatment in Yaoundé, Cameroon: first results of a national cross-sectional survey. Bull World Health Organ (2009) 1.42
Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr (2002) 1.41
Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa. PLoS One (2013) 1.41
Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther (2005) 1.40
Progressivity and horizontal equity in health care finance and delivery: what about Africa? Health Policy (2006) 1.38
Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials (2003) 1.36
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis. Acta Neuropathol (2010) 1.36
Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. J Acquir Immune Defic Syndr (2006) 1.35
'Time is costly': modelling the macroeconomic impact of scaling-up antiretroviral treatment in sub-Saharan Africa. AIDS (2008) 1.35
Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci (2014) 1.34
Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg (2007) 1.33
Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers. Health Policy (2009) 1.31
Discrimination against HIV-infected people and the spread of HIV: some evidence from France. PLoS One (2007) 1.27
Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116). Trop Med Int Health (2008) 1.26
Testing for BRCA1 mutations: a cost-effectiveness analysis. Eur J Hum Genet (2002) 1.26
Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public? Vaccine (2010) 1.24
Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Brain Pathol (2013) 1.22
Scaling up health policies and services in low- and middle-income settings. BMC Health Serv Res (2010) 1.22
The health-care system: an assessment and reform agenda. Lancet (2009) 1.19
Health related quality of life among both current and former injection drug users who are HIV-infected. Drug Alcohol Depend (2006) 1.18
Performance of HIV care decentralization from the patient's perspective: health-related quality of life and perceived quality of services in Cameroon. Health Policy Plan (2011) 1.12
Symptoms of depression in ICU physicians. Ann Intensive Care (2012) 1.10
Cost and cost-effectiveness of switching from d4T or AZT to a TDF-based first-line regimen in a resource-limited setting in rural Lesotho. J Acquir Immune Defic Syndr (2011) 1.09
Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study. J Sex Med (2011) 1.06
Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression. J Psychiatr Res (2010) 1.05
Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol (2006) 1.04
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma. Neuro Oncol (2013) 1.04
Parieto-temporal alpha EEG band power at baseline as a predictor of antidepressant treatment response with repetitive Transcranial Magnetic Stimulation: a preliminary study. J Affect Disord (2012) 1.04
Measuring and decomposing socioeconomic inequality in healthcare delivery: A microsimulation approach with application to the Palestinian conflict-affected fragile setting. Soc Sci Med (2010) 1.02
Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution. Ann Surg Oncol (2011) 1.01
HIV prevention: What have we learned from community experiences in concentrated epidemics? J Int AIDS Soc (2008) 1.01
Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease. Haematologica (2011) 1.00
Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital). S Afr Med J (2009) 1.00
High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas. Acta Neuropathol (2009) 0.99
Delayed first consultation after diagnosis of HIV infection in Cameroon. AIDS (2009) 0.98
Vascular reconstruction during pancreatoduodenectomy for ductal adenocarcinoma of the pancreas improves resectability but does not achieve cure. World J Surg (2010) 0.98
Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testing. Int J Technol Assess Health Care (2003) 0.98
Behavioural research in epidemics. Lancet Infect Dis (2013) 0.97
Development and validation of a questionnaire for quantitative assessment of perceived discomforts in critically ill patients. Intensive Care Med (2010) 0.97
Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth? PLoS One (2011) 0.97
Impoverishment and patients' "willingness" and "ability" to pay for improving the quality of health care in Palestine: an assessment using the contingent valuation method. Health Policy (2006) 0.97
Complications and treatment of patients with β-thalassemia in France: results of the National Registry. Haematologica (2009) 0.95
A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France. Mov Disord (2007) 0.94
The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia. Schizophr Res (2010) 0.94
A multifaceted intervention to improve the quality of care of children in district hospitals in Kenya: a cost-effectiveness analysis. PLoS Med (2012) 0.93
Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments. Eur Psychiatry (2005) 0.93
Equity in health care financing in Palestine: the value-added of the disaggregate approach. Soc Sci Med (2008) 0.93
Early severe morbidity and resource utilization in South African adults on antiretroviral therapy. BMC Infect Dis (2009) 0.93
Pandemic influenza (A/H1N1) vaccine uptake among French private general practitioners: a cross sectional study in 2010. PLoS One (2012) 0.91
The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa. Vaccine (2009) 0.91
The macroeconomic consequences of renouncing to universal access to antiretroviral treatment for HIV in Africa: a micro-simulation model. PLoS One (2012) 0.90
Heath-related quality of life in thyroid cancer patients following radioiodine ablation. Health Qual Life Outcomes (2011) 0.89
Economic implications of nonadherence to highly active antiretroviral treatment in HIV patients. Expert Opin Pharmacother (2006) 0.89
Understanding risk behaviours: how the sociology of deviance may contribute? The case of drug-taking. Soc Sci Med (2006) 0.89
Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines. BMC Cancer (2010) 0.89
Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings. BMC Health Serv Res (2010) 0.89
Prognostic factors in central neurocytomas: a multicenter study of 71 cases. Am J Surg Pathol (2012) 0.89
A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa. PLoS One (2013) 0.88
Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study. PLoS One (2012) 0.88
Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis. J Affect Disord (2013) 0.87
Infertility induced by cancer treatment: inappropriate or no information provided to majority of French survivors of cancer. Fertil Steril (2007) 0.87
Gender differences in experiences of ART services in South Africa: a mixed methods study. Trop Med Int Health (2012) 0.87
Smoking too few cigarettes to be at risk? Smokers' perceptions of risk and risk denial, a French survey. Tob Control (2007) 0.86
Prevention could be less cost-effective than cure: the case of hepatitis C screening policies in France. Int J Technol Assess Health Care (2003) 0.86
Peripheral blood cells chimerism after unrelated cord blood transplantation in children: kinetics, predictive factors and impact on post-transplant outcome. Br J Haematol (2014) 0.86
Predictive biomarkers investigated in glioblastoma. Expert Rev Mol Diagn (2014) 0.86
French physicians' attitudes toward legalisation of euthanasia and the ambiguous relationship between euthanasia and palliative care. J Palliat Care (2003) 0.86
Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116). AIDS Care (2010) 0.86
[Causes of death among 91 HIV-infected adults in the era of potent antiretroviral therapy]. Presse Med (2012) 0.86
Venice Statement on global health initiatives and health systems. Lancet (2009) 0.85
Morphine prescription in end-of-life care and euthanasia: French home nurses' opinions. J Opioid Manag (2007) 0.85
Assessment of quality of life of the children and parents affected by inborn errors of metabolism with restricted diet: preliminary results of a cross-sectional study. Health Qual Life Outcomes (2013) 0.85
Relevance of quality of life assessment for multiple sclerosis patients with memory impairment. PLoS One (2012) 0.85
Call for action to secure universal access to ART in developing countries. Lancet (2010) 0.84
Changing time and emotions. Philos Trans R Soc Lond B Biol Sci (2010) 0.84